Welcome back to Health Tech Checkup! Hosts Perry Dimas and Rachel Gallant are joined by Dr. Rebecca Miksad, Chief Medical Officer at Color, for a conversation about what it actually takes to deliver guideline-quality cancer care at scale. Where does AI genuinely help? Where does it still need to earn our trust? Dr. Miksad, a Harvard-trained medical oncologist who moved from treating GI cancer patients into digital health strategy, walks through the gaps that pulled her out of the clinic and into building systems: patients getting younger and younger colon cancer diagnoses, life-changing trial data that never reaches the people who need it, and a survivorship crisis that's almost invisible — there are 8 to 10 times more cancer survivors than active cancer patients in any given population, yet primary care physicians rarely get trained to support them once treatment ends. The conversation covers how Color's 50-state virtual cancer clinic works — the first (and currently only) virtual practice to earn ASCO certification — and what that certification actually required: meeting the same seven domains of care (patient engagement, 24/7 availability, evidence-based medicine, comprehensive team-based care, quality improvement, goals-of-care conversations, and antineoplastic therapy safety) that brick-and-mortar Centers of Excellence are held to. Perry, Rachelle and Rebecca also dig into: A real patient case where a multidisciplinary tumor board caught a rarer-than-expected cancer diagnosis and opened up a clinical trial the patient wouldn't otherwise have foundWhy something as simple as scheduling an at-home infusion can be a logistical black box for both patients and their own oncologists — and how removing that friction improves cost, convenience, and adherence all at onceWhere Rebecca sees AI genuinely working today (matching patients to coverage, reducing administrative friction, identifying at-risk patients in the EHR) versus where it still needs more validation (direct clinical decision-making)The sobering stat that only 14% of eligible patients actually get the lung cancer screening they're guideline-eligible for — a reminder that some of the biggest gaps in cancer care aren't about new technology at all, but about using the tools we already havePlus: the "three worst words in the English language," why survivorship care deserves as much attention as treatment, and what Rebecca hopes we better understand about trusting AI in oncology over the next five years. Subscribe to HealthTech Check Up to stay up to date on where tech meets care, and leave us a review if you’re enjoying the show! —------- Keep in touch with our hosts, Rachelle Galant and Perry Dimas on Linkedin! To learn more about careviso, visit, www.careviso.com